- Home
- UFI vs ANVS Comparison
UFI vs ANVS Comparison
Compare UFI & ANVS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- UFI
- ANVS
- Stock Information
- Founded
- UFI 1969
- ANVS 2008
- Country
- UFI United States
- ANVS United States
- Employees
- UFI N/A
- ANVS N/A
- Industry
- UFI Textiles
- ANVS Biotechnology: Pharmaceutical Preparations
- Sector
- UFI Consumer Discretionary
- ANVS Health Care
- Exchange
- UFI Nasdaq
- ANVS Nasdaq
- Market Cap
- UFI N/A
- ANVS 92.6M
- IPO Year
- UFI N/A
- ANVS 2020
- Fundamental
- Price
- UFI $5.52
- ANVS $4.37
- Analyst Decision
- UFI
- ANVS Strong Buy
- Analyst Count
- UFI 0
- ANVS 6
- Target Price
- UFI N/A
- ANVS $29.67
- AVG Volume (30 Days)
- UFI 53.5K
- ANVS 314.9K
- Earning Date
- UFI 01-29-2025
- ANVS 11-08-2024
- Dividend Yield
- UFI N/A
- ANVS N/A
- EPS Growth
- UFI N/A
- ANVS N/A
- EPS
- UFI N/A
- ANVS N/A
- Revenue
- UFI $590,737,000.00
- ANVS N/A
- Revenue This Year
- UFI $11.45
- ANVS N/A
- Revenue Next Year
- UFI $6.84
- ANVS N/A
- P/E Ratio
- UFI N/A
- ANVS N/A
- Revenue Growth
- UFI 1.35
- ANVS N/A
- 52 Week Low
- UFI $5.41
- ANVS $4.31
- 52 Week High
- UFI $7.91
- ANVS $22.49
- Technical
- Relative Strength Index (RSI)
- UFI 38.91
- ANVS 26.09
- Support Level
- UFI $5.48
- ANVS $5.24
- Resistance Level
- UFI $5.65
- ANVS $5.21
- Average True Range (ATR)
- UFI 0.15
- ANVS 0.51
- MACD
- UFI 0.04
- ANVS -0.10
- Stochastic Oscillator
- UFI 32.14
- ANVS 1.89
About ANVS Annovis Bio Inc.
Annovis Bio Inc is a clinical-stage pharmaceutical company focused on developing and commercializing drugs for the treatment of Parkinson's and Alzheimer's diseases and other neurodegenerative diseases. The pipeline products of the company consists of: Buntanetap for chronic neurodegeneration - including AD and PD; ANVS405 for acute neurodegeneration; and ANVS301 for advanced AD.